On 7 October the online training series on the treatment of the harms produced by novel psychoactive substances and club drugs kicked-off. This activity has been designed and will be delivered in partnership with the European Union 4 Monitoring Drugs project (EU4MD), an initiative of the EMCDDA and the Novel Psychoactive Treatment United Kingdom Network (NEPTUNE), led by the UK National Health Service (NHS). Participants in the training include clinicians and psychiatrists from Belarus, Georgia, Moldova, Pakistan and Ukraine. Read more about this news here.
Meanwhile, the EU-ACT project officially handed over to the Ukraine State Financial Monitoring Service (SFMS), 13 computers. This resource allocation was made at a three-day course, attended by 20 analysts, and designed to teach the use of i2 analytical tool in support of Financial Investigations. This equipment supports the use of the latest version of the i2 Analyst Notebook and provides essential modern functionality for officers to analyse data indicating financial transactions. This new procurement and the associated activities are testimony of two years of solid cooperation between the SFMS and EU-ACT. Read more about this activity and the cooperation between the SFMS and EU-ACT here.
Building on a history of success, EU-ACT maintains its support to Georgia in the drafting of its National Anti-Drug Action Plan. The support was initiated back in 2018 at two workshops that concentrated on the drafting of the plan covering 2019-2020. The Project continues to support the next phase of the plan covering 2021-2022 by hosting a workshop that brings together several institutional stakeholders involved in the development and implementation of drug policies in Georgia, namely: the Ministry of Justice, the National Drug Observatory, the Ministry of Internal Affairs, the Office of the Resource Officers of the Educational Institutions, the Revenue Service, the Prosecutor’s Office, the Special Penitentiary Service, the National Agency for Crime Prevention and Probation and the National Centre for Disease Control and Public Health. Read more here.
In September, EU-ACT, in partnership with the National Centre for Disease Control and Public Health (NCDC) and the National Monitoring Centre on Drugs (NMC) provided workshops to showcase the EMCDDA Treatment indicator and the associated electronic form that will become mandatory for providers to complete in 2021.
Read more about partnership between EU-ACT and Georgia here
Read more about partnership between EU-ACT and Ukraine here
